These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 5635434)

  • 1. Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid.
    Summerskill WH; Thorsell F; Feinberg JH; Aldrete JS
    Gastroenterology; 1968 Jan; 54(1):20-6. PubMed ID: 5635434
    [No Abstract]   [Full Text] [Related]  

  • 2. Ammonia production in the human colon. Effects of cleansing, neomycin and acetohydroxamic acid.
    Wolpert E; Phillips SF; Summerskill WH
    N Engl J Med; 1970 Jul; 283(4):159-64. PubMed ID: 5424005
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of arginine malate in experimental and clinical hyperammonemia].
    Szãm I; Szentner J; Hegedüs-Wein I; Vass A
    Int J Clin Pharmacol; 1972 Aug; 6(3):260-5. PubMed ID: 4648469
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 5. Helicobacter pylori and plasma ammonia levels in cirrhotics: role of urease inhibition by acetohydroxamic acid.
    Zullo A; Rinaldi V; Hassan C; Folino S; Winn S; Pinto G; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):405-9. PubMed ID: 9789138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of urea in the hyperammonemia of germ-free Eck fistula dogs.
    Nance FC; Kaufman HJ; Kline DG
    Gastroenterology; 1974 Jan; 66(1):108-12. PubMed ID: 4809488
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to the treatment of portal systemic encephalopathy (author's transl)].
    Blahníková L; Horký J; Pechar J; Honzák R; Vosmík J
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):486-93. PubMed ID: 737756
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic buffers in hepatic failure.
    Grossi CE; Prytz B; Rousselot LM
    Surgery; 1968 Nov; 64(5):928-33. PubMed ID: 5687843
    [No Abstract]   [Full Text] [Related]  

  • 9. [Some problems of hyperammonemia].
    Tarnawski A; Batko B
    Przegl Lek; 1969; 25(8):568-72. PubMed ID: 4897432
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels].
    Müting D
    Clin Ter; 1967 Aug; 42(4):289-97. PubMed ID: 5608820
    [No Abstract]   [Full Text] [Related]  

  • 11. Helicobacter pylori urease inhibition and ammonia levels in cirrhotic patients.
    Zullo A; Rinaldi V; Folino S; Diana F; Attili AF
    Am J Gastroenterol; 1998 May; 93(5):851-2. PubMed ID: 9625155
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extension of indications for portal shunt operation through the management of postoperative liver decompensation with peritoneal dialysis].
    Kraemer HJ
    Munch Med Wochenschr; 1968 Feb; 110(7):406-9. PubMed ID: 5695059
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
    Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD
    Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cirrhosis, hyperammonemia and Lactulose.
    Rottiers R; Van Egmond J; Verbruggen R; Dierick G; Vermeulen A; Standaert L; De Groote J; Demeulenaere L
    Tijdschr Gastroenterol; 1968; 11(2):123-39. PubMed ID: 5679042
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolic changes following termino-lateral portacaval anastomosis in the rat].
    Remonda G; Massaglia F; Pugnani M; Dotti G; Natale G; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1983; 26(1-6):172-82. PubMed ID: 6149721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of hyperammonemia in liver diseases with special reference to neomycin].
    Gniwotta E; Neumann-Mangold P; Schalm J
    Z Allgemeinmed; 1974 Feb; 50(4):188-91. PubMed ID: 4824471
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hepatic coma.
    Spellberg MA
    Am J Gastroenterol; 1969 Feb; 51(2):118-28. PubMed ID: 4887357
    [No Abstract]   [Full Text] [Related]  

  • 19. Exchange transfusion in hepatic coma. A review of 19 cases.
    McKechnie JC; Hersh T
    Am J Gastroenterol; 1971 Jul; 56(1):17-43. PubMed ID: 5564900
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.